title: Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model.
abstract: A human oral tumour progression model was established that consists of normal epithelial cells and three cell lines representing stages from dysplastic to metastatic cells. To investigate the impact of exogenous transforming growth factor-beta 1 on this model system, we analysed the responsiveness of those cells to transforming growth factor-beta 1 and explored the potential mechanism underlying the transforming growth factor-beta 1 activity. We found that the growth of all cell types, regardless of their stage of tumour progression, is inhibited by transforming growth factor-beta 1, although to different degrees. Transforming growth factor-beta 1 induced the expression of cyclin-dependent kinase inhibitors p15(INK4B), p21WAF1/(CIP1) and p27(KIP1). In contrast, transforming growth factor-beta 1 was found to stimulate the invasive potential of one cell type that represents the most advanced stage of tumour phenotype, suggesting that the impact of transforming growth factor-beta 1 on functional features of tumour cells other than cellular proliferation may play a significant role in the process of oral tumour progression.
authors.affiliation: Department of Oral Biology and Maxillofacial Pathology, Medical College of Georgia, Augusta, GA 30912-1126, USA. shsu@mail.mcg.edu
authors.forename: S
authors.initials: S
authors.lastname: Hsu
authors.forename: J L
authors.initials: JL
authors.lastname: Borke
authors.forename: J B
authors.initials: JB
authors.lastname: Lewis
authors.forename: B
authors.initials: B
authors.lastname: Singh
authors.forename: A C
authors.initials: AC
authors.lastname: Aiken
authors.forename: C T
authors.initials: CT
authors.lastname: Huynh
authors.forename: G S
authors.initials: GS
authors.lastname: Schuster
authors.forename: G B
authors.initials: GB
authors.lastname: Caughman
authors.forename: D P
authors.initials: DP
authors.lastname: Dickinson
authors.forename: A K
authors.initials: AK
authors.lastname: Smith
authors.forename: T
authors.initials: T
authors.lastname: Osaki
authors.forename: X F
authors.initials: XF
authors.lastname: Wang
mesh_terms: D021581:Active Transport, Cell Nucleus; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology; D018797:Cell Cycle Proteins / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000502:physiology; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000378:metabolism* / Q000473:pathology; D051900:Smad3 Protein; D015534:Trans-Activators / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1; D014407:Tumor Cells, Cultured
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C497790:SMAD3 protein, human; D051900:Smad3 Protein; C508960:TGFB1 protein, human; D015534:Trans-Activators; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1